Final Programme - iuphar

More documents

Recommendations

Info

FC15 Endothelium in health and disease Thu 241 TLR3 and TLR4 ligands induce intracellular IL-1β immunoreactivity in human aortic endothelial cells (HAEC) and lung microvascular endothelial cells (HLMVECs) Daniel M Reed, (UK), WR Wright, CMF Potter, HH Gashaw, LK Bailey, M Paul-Clark, JA Mitchell Thu 242 Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in renovascular hypertension Vincent Richard, (France), J Gao, E Gomez, B Dautreaux, F Bounoure, M Skiba, C Thuillez, J Bellien Thu 243 Improved vascular function and altered cardiac phenotype in mice overexpressing melanocytestimulating hormone Petteri Rinne, (Finland), I Heinonen, A Saraste, ST Ruohonen, S Ruohonen, E Savontaus Thu 244 Non-invasive laser speckle contrast imaging to assess skin microvascular reactivity in humans Matthieu Roustit, (France), C Millet, S Blaise, B Dufournet, J-L Cracowski Thu 245 Cathodal iontophoresis of treprostinil and iloprost induce a sustained increase in skin blood flow in rats Matthieu Roustit, (France), S Blaise, C Ribuot, C Millet, J-L Cracowski Thu 246 Differences in the in vitro antiplatelet effect of dexibuprofen, ibuprofen and flurbiprofen in human blood Maria Isabel Ruiz-Moreno, (Spain), JJ Reyes-Vega, JA Lopez-Villodres, N Jebrouni, JA Gonzalez-Correa, JP de la Cruz Thu 247 Effect of cinnamaldehyde (C) on vascular function in diabetic rats Ramzi Sabra, (Lebanon), M Khalaf Thu 248 Involvement of secretory phospholipase A2 in stretch-induced aberrant contraction in pulmonary arteries isolated from pulmonary hypertensive rats Maki Saito, (Japan), Y Tanabe, A Kamataki, T Sawai, K Nakayama Thu 249 Differential COX-2-mediated arachidonic acid metabolism in coronary and penile arteries from prediabetic obese Zucker rats A Sánchez, C Contreras, N Villalba, P Martínez, A García-Sacristán, M Hernández, Dolores Prieto, (Spain) Thu 250 Thyroid hormone up-regulates elastin and lysyl oxidase genes in rat aorta Mitsutoshi Satoh, (Japan), S Yanagino, T Nishimaki-Mogami, K Suzuki, Y Sato Thu 251 NO synthase and Thrombospondin-1 in the initiation of flow-related reModelling of rat mesenteric resistance arteries Paul Schiffers, (The Netherlands), P Lemkens, G Boari, G Fazzi, G Janssen, J Murphy-Ullrich, J De Mey Thu 252 Distinct NADPH-cytochrome P450 reductase dependence of heme oxygenase-1 and heme oxygenase-2 Monika Seeanner, (Germany), JR Kraehling, M Busker, S Behrends Thu 253 In vitro dissolution kinetics studies of amlodipine tablets marketed in Russia under biowaiver conditions IE Shohin, GV Ramenskaya, GF Vasilenko, EA Malashenko, KS Davydova, Dmitry A Sychev, (Russian Federation), VG Kukes Thu 254 Role of AT1 and AT2 receptor and NAD(P)H oxidase on angiotensin II-stimulated antioxidant enzymes activity in the rat hypothalamus Jose Silva, (Venezuela), M Pastorello, S De Jesus, MG Matos, MR Garrido, A Israel Thu 255 Potential beneficial effect of ergothioneine in protecting endothelial dysfunction Albert SM Sit, (PR China), EYW Ho, RWS Li, YW Kwan, M Hausman, PM Vanhoutte, GPH Leung 298 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC15 Endothelium in health and disease Thu 256 Statin-dependent effects on vascular tone and gene expression in human endothelial cells Cristine Skogastierna, (Sweden), L Luksha, K Kublickiene, E Eliasson, A Rane, L Ekström Thu 257 Adding ezetimibe to statin halts progression of carotid plaque J David Spence, (Canada) Thu 258 Involvement of endothelial sphingolipid metabolism in release and action of endothelium-derived contracting factors Léon Spijkers, (The Netherlands), R van der Akker, A Alewijnse, S Peters Thu 259 Small and intermediate calcium-activated K channels are involved in release of NO and EDHF in small arteries Edgaras Stankevicius, (Denmark), C Krøjgaard, T Dalsgaard, L Beck, AD Hughes, U Simonsen Thu 260 Electropharmacological analysis of triggered activity in the pulmonary vein myocardium of the guinea pig Akira Takahara, (Japan), T Sugimoto, K Takeda, I Namekata, H Tanaka Thu 261 Proton mediates perivascular adrenergic and CGRPericg neurotransmission in the rat mesenteric artery Shingo Takatori, (Japan), K Hirai, H Fujiwara, X Jin, S Egutchi, Y Kitamura, H Kawasaki Thu 262 ω6-polyunsatulated fatty acids, but not other free fatty acids, evoke endothelial dysfunction by inhibiting store-operated Ca2+ entries Kazuhiko Takeuchi, (Japan), J Wei, N Inui, H Watanabe Thu 263 Different contributions of Rho-kinase to the vasoconstrictions caused by 5-HT and noradrenalin in the isolated human internal thoracic artery and saphenous vein Naoko Tanaka, (Japan), T Kanai, Y Matsuo, M Kuwabara, E Nakamura, K Nakamura, Y Asada, H Hisa, R Yamamoto Thu 264 Impaired arterial smooth muscle calcium signalling and ultrastructural deterioration appear linked in the elderly Teresa Tejerina, (Spain), J Navarro-Dorado, M Alonso, M Ramajo, S Redondo, C van Breemen, N Fameli Thu 265 Renovascular hypertension increases the hypothalamic content of serotonin in rats José A Terrón, (Mexico), B García-Iglesias, I López-Islas Thu 266 FP and TP receptors are responsible for increased vasoconstriction induced by Prostaglandin F2α in preeclamptic human umbilical vein Gokce Topal Tanyilmaz, (Turkey), SB Uydes Dogan, M Kucur, A Gezer, R Madazli, O Ozdemir, X Norel Thu 267 Endothelial cells during a parabolic flight – which changes appear? C Ulbrich, Jessica Pietsch, (Germany), J Bauer, D Grimm Thu 268 Protective effect of amlodipine against the decrease in bone density in rats Kentarou Ushijima, (Japan), Y Liu, E Ishikawa, T Maekawa, Y Motosugi, H Ando, A Fujimura Thu 269 Sensitivity to Rho kinase inhibitor Y-27632 is increased in the mesenteric arteries of L-NAME hypertensive rats B Sonmez Uydes-Dogan, (Turkey), F Gezerler, S Takir, FI Alp, O Ozdemir Thu 270 Genomic changes caused by chronic exposure to high cholesterol or fish oil in native and regenerated porcine coronary endothelial cells Paul M Vanhoutte, (PR China), MYK Lee, Y Wang, HF Tse Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 299
Page 1:
of basic and clinical pharmacology
Page 4 and 5:
Congress patron 2 HRH Crown Princes
Page 6 and 7:
Congress President Kim Brøsen Secr
Page 8 and 9:
General information Registration &
Page 10 and 11:
Banks, currency & credit cards The
Page 12 and 13:
Information to presenters ■ The a
Page 14 and 15:
Hotel Bella Center Copenhagen Groun
Page 16 and 17:
Programme at a glance Time Hall A2
Page 18 and 19:
16 General events General events Op
Page 20 and 21:
Programme outline Plenary lectures
Page 22 and 23:
FC10 Drugs for half the world: Paed
Page 24 and 25:
Tue 12:45 W13 Workshop: Novel perip
Page 26 and 27:
W01 Pharmacology of adrenoceptors:
Page 28 and 29:
W02 Symposium on advances in GI pha
Page 30 and 31:
W04 Symposium: Antioxidants as ther
Page 32 and 33:
Plenary lectures PL01 Plenary lectu
Page 34 and 35:
FC02 Transmembrane transport: Persp
Page 36 and 37:
FC04 Pharmacoepidemiology, current
Page 38 and 39:
FC06 The heart gone wrong: Stabiliz
Page 40 and 41:
FC09 Inflammation and immunopharmac
Page 42 and 43:
Page 44 and 45:
SS01 Sponsored symposium Sponsored
Page 46 and 47:
W06 Workshop. Effect of disease on
Page 48 and 49:
W08 Workshop. Identifying targets f
Page 50 and 51:
W10 Workshop. Innovative Medicines
Page 52 and 53:
FC01 Clinical pharmacology in the e
Page 54 and 55:
FC03 Ion channels in analgesia and
Page 56 and 57:
FC05 Translational science in the m
Page 58 and 59:
Page 60 and 61:
FC08 Development in the treatment o
Page 62 and 63:
Plenary lectures PL04 Plenary lectu
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
FC07 Simulation and data modelling
Page 72 and 73:
Page 74 and 75:
W12 Workshop. Experimental pain met
Page 76 and 77:
W14 Workshop. Translating the human
Page 78 and 79:
W15 Workshop. The IUPHAR initiative
Page 80 and 81:
W17 Workshop. Standards for PhD Edu
Page 82 and 83:
W19 Workshop. Influence of degenera
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
FC08 Development in the treatment o
Page 92 and 93:
PL10 ASPET Plenary Lecture Chair: T
Page 94 and 95:
Page 96 and 97:
FC12 Ion channelopathies: New windo
Page 98 and 99:
FC14 Addiction and doping: Neurobio
Page 100 and 101:
FC17 New approaches and targets in
Page 102 and 103:
W04 Symposium: Antioxidants as ther
Page 104 and 105:
W21 Workshop. Inflammation - here,
Page 106 and 107:
W23 Workshop. Applying pharmacogeno
Page 108 and 109:
W25 Workshop. High science in the l
Page 110 and 111:
W27 Workshop. Approaches to medicin
Page 112 and 113:
FC11 G protein-coupled 7TM receptor
Page 114 and 115:
FC13 Maximising benefits and minimi
Page 116 and 117:
FC15 Endothelium in Health and dise
Page 118 and 119:
Page 120 and 121:
FC18 Nuclear receptor targets for t
Page 122 and 123:
PL16 Plenary Lecture Supported by a
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
FC15 Endothelium in Health and dise
Page 130 and 131:
Page 132 and 133:
W28 Workshop. The Boehringer-Ingelh
Page 134 and 135:
W30 Workshop. Is eNOS still a valid
Page 136 and 137:
W32 Workshop. The good, the bad and
Page 138 and 139:
W34 Workshop. State-of-the-art of b
Page 140 and 141:
FC10 Drugs for half the world: Pedi
Page 142 and 143:
FC12 Ion channelopathies: New windo
Page 144 and 145:
FC14 Addiction and doping: Neurobio
Page 146 and 147:
FC16 Natural products: Past and fut
Page 148 and 149:
FC18 Nuclear receptor targets for t
Page 150 and 151:
PL22 Plenary Lecture Chair: Zhi-Bin
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
FC15 Endothelium in health and dise
Page 158 and 159:
Page 160 and 161:
158
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
W12 Experimental pain methods in de
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
FC06 The heart gone wrong; stabiliz
Page 180 and 181:
Page 182 and 183:
FC08 Developments in the treatment
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
W03 Targeting TRP channels for pain
Page 196 and 197:
W19 Influence of degeneration and r
Page 198 and 199:
W19 Influence of degeneration and r
Page 200 and 201:
W20 Pharmacology education for a su
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
FC06 The heart gone wrong; stabiliz
Page 216 and 217:
Page 218 and 219:
FC08 Developments in the treatment
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
FC19 General session Tue 361 Analge
Page 232 and 233:
FC19 General session - Biologics Tu
Page 234 and 235:
FC19 General session - Haematology
Page 236 and 237:
FC19 General session - oncology Tue
Page 238 and 239:
FC19 General session - oncology Tue
Page 240 and 241:
FC19 General session - Toxicology T
Page 242 and 243:
Page 244 and 245:
W11 New opportunities in the pharma
Page 246 and 247:
W23 Applying pharmacogenomics (PGX)
Page 248 and 249:
Page 250 and 251: FC11 G protein-coupled 7TM receptor
Page 254 and 255: FC12 Ion channelopathies: New windo
Page 256 and 257: FC13 Maximising benefits and minimi
Page 260 and 261: FC14 Addiction and doping: Neurobio
Page 262 and 263: FC15 Endothelium in health and dise
Page 268 and 269: W30 Is eNOS Still a valid therapeut
Page 270 and 271: FC16 Natural products: Past and fut
Page 276 and 277: FC17 New approaches and targets in
Page 280 and 281: W34 State-of-the-art of basic and c
Page 282 and 283: FC10 Drugs for half the world: Paed
Page 294 and 295: W29 New horizons in therapeutic dru
Page 296 and 297: FC14 Addiction and doping: Neurobio
Page 314 and 315: FC18 Nuclear receptor targets for t
Page 316 and 317: 314 Index Name Paper ref. Name Pape
Page 350 and 351:
348 Index Name Paper ref. Name Pape
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
382 Notes Notes
Page 386:
Final Programme printed in Singapor
show all

Final Programme - iuphar

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?